{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:24:16Z","timestamp":1791923056671,"version":"4.3.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["UMO-2018\/31\/D\/ST4\/00109"],"award-info":[{"award-number":["UMO-2018\/31\/D\/ST4\/00109"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jpba.2024.115966","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T11:39:44Z","timestamp":1704713984000},"page":"115966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Untargeted metabolomics of bladder tissue using liquid chromatography and quadrupole time-of-flight mass spectrometry for cancer biomarker detection"],"prefix":"10.1016","volume":"240","author":[{"given":"Joanna","family":"Nizio\u0142","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Ossoli\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneta","family":"P\u0142aza-Altamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Ko\u0142odziej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ossoli\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadeusz","family":"Ossoli\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzanna","family":"Krupa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Ruman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2024.115966_bib1","first-page":"209","article-title":"Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.jpba.2024.115966_bib2","first-page":"1","article-title":"The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection","volume":"8","author":"Wong","year":"2018","journal-title":"Sci. Rep. 2018"},{"key":"10.1016\/j.jpba.2024.115966_bib3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.mpsur.2019.07.003","article-title":"Bladder cancer","volume":"37","author":"Mushtaq","year":"2019","journal-title":"Surg. (Oxf. )"},{"key":"10.1016\/j.jpba.2024.115966_bib4","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/cam4.1109","article-title":"Metabolomics analysis reveals distinct profiles of nonmuscle-invasive and muscle-invasive bladder cancer","volume":"6","author":"Sahu","year":"2017","journal-title":"Cancer Med"},{"key":"10.1016\/j.jpba.2024.115966_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2023.115074","article-title":"Proteomics strategies for urothelial bladder cancer diagnosis, prognosis and treatment: Trends for tumor biomarker sources","volume":"666","author":"Tabaei","year":"2023","journal-title":"Anal. Biochem"},{"key":"10.1016\/j.jpba.2024.115966_bib6","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1039\/C9RA08985C","article-title":"Mass spectrometry-based metabolomics in health and medical science: a systematic review","volume":"10","author":"Zhang","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.jpba.2024.115966_bib7","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.3390\/ijms23084173","article-title":"Metabolomic approaches for detection and identification of biomarkers and altered pathways in bladder cancer","volume":"23","author":"Di Meo","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.jpba.2024.115966_bib8","article-title":"Metabolomics for the diagnosis of bladder cancer: a systematic review","author":"Garc\u00eda-Perdomo","year":"2023","journal-title":"Asian J. Urol."},{"key":"10.1016\/j.jpba.2024.115966_bib9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/14737159.2019.1656530","article-title":"The applications of metabolomics in the molecular diagnostics of cancer","volume":"19","author":"Cheung","year":"2019","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"1","key":"10.1016\/j.jpba.2024.115966_bib10","first-page":"1","article-title":"Statistical methods and resources for biomarker discovery using metabolomics","volume":"24","author":"Anwardeen","year":"2023","journal-title":"BMC Bioinforma. 2023"},{"key":"10.1016\/j.jpba.2024.115966_bib11","doi-asserted-by":"crossref","first-page":"7376","DOI":"10.1158\/0008-5472.CAN-11-1154","article-title":"Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression","volume":"71","author":"Putluri","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpba.2024.115966_bib12","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1021\/pr4004135","article-title":"HR-MAS NMR tissue metabolomic signatures cross-validated by mass spectrometry distinguish bladder cancer from benign disease","volume":"12","author":"Tripathi","year":"2013","journal-title":"J. Proteome Res"},{"key":"10.1016\/j.jpba.2024.115966_bib13","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.euf.2017.04.005","article-title":"Distinct lipidomic landscapes associated with clinical stages of urothelial cancer of the bladder","volume":"4","author":"Piyarathna","year":"2018","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.jpba.2024.115966_bib14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.advms.2022.12.002","article-title":"Monoisotopic silver nanoparticles-based mass spectrometry imaging of human bladder cancer tissue: Biomarker discovery","volume":"68","author":"Ossoli\u0144ski","year":"2023","journal-title":"Adv. Med Sci."},{"key":"10.1016\/j.jpba.2024.115966_bib15","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.euf.2017.04.005","article-title":"Distinct lipidomic landscapes associated with clinical stages of urothelial cancer of the bladder","volume":"4","author":"Piyarathna","year":"2018","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.jpba.2024.115966_bib16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/14737140.2022.2070154","article-title":"Progress in the development of tissue-based biomarkers for urothelial cancer","volume":"22","author":"Bhanvadia","year":"2022","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.jpba.2024.115966_bib17","article-title":"Fluorescence guided surgery","volume":"9","author":"Stewart","year":"2021","journal-title":"Methods Appl. Fluor."},{"key":"10.1016\/j.jpba.2024.115966_bib18","doi-asserted-by":"crossref","DOI":"10.1007\/s11306-021-01779-2","article-title":"Metabolomic and elemental profiling of human tissue in kidney cancer","volume":"17","author":"Nizio\u0142","year":"2021","journal-title":"Metabolomics"},{"key":"10.1016\/j.jpba.2024.115966_bib20","unstructured":"Mass Spectrometry Data Center, NIST, (n.d.). \u3008https:\/\/chemdata.nist.gov\/\u3009 (Accessed 8 June\u00a02022)."},{"key":"10.1016\/j.jpba.2024.115966_bib21","doi-asserted-by":"crossref","first-page":"W388","DOI":"10.1093\/nar\/gkab382","article-title":"MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights","volume":"49","author":"Pang","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.jpba.2024.115966_bib22","first-page":"1","article-title":"Untargeted urinary metabolomics for bladder cancer biomarker screening with ultrahigh-resolution mass spectrometry","volume":"13","author":"Nizio\u0142","year":"2023","journal-title":"Sci. Rep. 2023"},{"key":"10.1016\/j.jpba.2024.115966_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115473","article-title":"Targeted and untargeted urinary metabolic profiling of bladder cancer","volume":"233","author":"Ossoli\u0144ski","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.115966_bib24","doi-asserted-by":"crossref","first-page":"W423","DOI":"10.1093\/nar\/gkn282","article-title":"KEGG Atlas mapping for global analysis of metabolic pathways","volume":"36","author":"Okuda","year":"2008","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.jpba.2024.115966_bib25","first-page":"1","article-title":"Untargeted ultra-high-resolution mass spectrometry metabolomic profiling of blood serum in bladder cancer","volume":"12","author":"Nizio\u0142","year":"2022","journal-title":"Sci. Rep. 2022"},{"key":"10.1016\/j.jpba.2024.115966_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1320.001","article-title":"The role of the carnitine system in human metabolism","volume":"1033","author":"Foster","year":"2004","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.jpba.2024.115966_bib27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem Sci."},{"key":"10.1016\/j.jpba.2024.115966_bib28","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.18632\/oncotarget.1744","article-title":"Diagnosis of bladder cancer and prediction of survival by urinary metabolomics","volume":"5","author":"Jin","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.jpba.2024.115966_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115870","article-title":"Bladder cancer biomarker discovery using global metabolomic profiling of urine","volume":"9","author":"Wittmann","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jpba.2024.115966_bib30","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1007\/s00216-018-1059-x","article-title":"Metabolomic study of human tissue and urine in clear cell renal carcinoma by LC-HRMS and PLS-DA","volume":"410","author":"Nizio\u0142","year":"2018","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2024.115966_bib31","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.biocel.2012.06.025","article-title":"Delineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A2, a potential therapeutic target","volume":"44","author":"Tripathi","year":"2012","journal-title":"Int J. Biochem Cell Biol."},{"key":"10.1016\/j.jpba.2024.115966_bib32","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.bcp.2007.04.021","article-title":"Phospholipase A2 as targets for anti-cancer drugs","volume":"74","author":"Cummings","year":"2007","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.jpba.2024.115966_bib33","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jprot.2015.05.013","article-title":"LC\u2013MS-based serum metabolomic analysis reveals dysregulation of phosphatidylcholines in esophageal squamous cell carcinoma","volume":"127","author":"Mir","year":"2015","journal-title":"J. Proteom."},{"key":"10.1016\/j.jpba.2024.115966_bib34","doi-asserted-by":"crossref","first-page":"13231","DOI":"10.18632\/oncotarget.24229","article-title":"Reprogrammed lipid metabolism in bladder cancer with cisplatin resistance","volume":"9","author":"Lee","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jpba.2024.115966_bib35","doi-asserted-by":"crossref","first-page":"10795","DOI":"10.1158\/0008-5472.CAN-06-0755","article-title":"Mass spectrometry\u2013based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors","volume":"66","author":"Denkert","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpba.2024.115966_bib36","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1021\/pr4000448","article-title":"Urinary metabotyping of bladder cancer using two-dimensional gas chromatography time-of-flight mass spectrometry","volume":"12","author":"Pasikanti","year":"2013","journal-title":"J. Proteome Res"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524000062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524000062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:37:54Z","timestamp":1760002674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524000062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":35,"alternative-id":["S0731708524000062"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.115966","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Untargeted metabolomics of bladder tissue using liquid chromatography and quadrupole time-of-flight mass spectrometry for cancer biomarker detection","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.115966","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115966"}}